Filing Details
- Accession Number:
- 0001209191-19-003177
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2019-01-09 21:08:06
- Reporting Period:
- 2019-01-02
- Accepted Time:
- 2019-01-09 21:08:06
- Original Submission Date:
- 2019-01-04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1711675 | Nightstar Therapeutics Plc | NITE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1761163 | Scott Gregory Robinson | C/O Nightstar, Inc. 203 Crescent Street, Suite 303 Waltham MA 02453 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2019-01-02 | 14,764 | $11.15 | 104,017 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The ordinary shares, nominal value GBP 0.01 per share, of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person
- On January 4, 2019, a Form 4 was filed to report the January 2, 2019 sale of 14,764 ordinary shares pursuant a 10b5-1 plan previously adopted by the Reporting Person. The report provided by the Issuer's equity administrator contained errors relating to the Reporting Person's holdings which have been corrected herein. This Form 4/A amends and restates, in its entirety, the original Form 4.
Billionaire Hedge Funds
